查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1829890

2025年穿戴式註射器全球市场报告

Wearable Injectors Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，穿戴式註射器市场快速扩张，市场规模从2024年的88.4亿美元成长至2025年的98.4亿美元，复合年增长率达11.3%。预测期内的成长可归因于慢性病管理、患者便利性、技术进步以及人口老化。

穿戴式註射器市场规模预计在未来几年内将快速成长，到2029年将达到172亿美元，年复合成长率（CAGR）为15.0%。预测期内的成长主要由个人化医疗、远端患者监护、药物开发和慢性病管理推动。预测期内的主要趋势包括生技药品和大分子、双腔穿戴式装置、连网型设备以及贴片帮浦技术。

穿戴式註射器是一种专门的药物输送装置，它附着在患者的身体上，在预定的时间内内皮下注射药物。

这些穿戴式註射器主要分为两种：体内注射器和体外注射器。体内注射器是直接佩戴在患者皮肤上的药物输送装置，通常佩戴在腹部或腋下。它们应用于免疫肿瘤学、糖尿病和心血管疾病等多个医疗领域，并在医院、诊所和居家医疗等各种医疗环境中使用。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备行业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制价格上涨，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要重新认证医疗设备，导致市场进入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司（The Business Research Company）新报告系列的一部分，该系列提供可穿戴注射器市场统计数据，包括可穿戴注射器行业的全球市场规模、各地区市场份额、可穿戴注射器市场份额竞争对手、可穿戴注射器市场细分、市场趋势和商机，以及您在可穿戴注射器行业取得成功所需的数据。本穿戴式註射器市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切观点。

我们预测未来五年该市场将成长15.0%，较先前预测略有下降0.2%。下降的主要原因是美国与其他国家之间的关税影响。这种影响可能会直接波及美国，导致来自印度和墨西哥等主要地区的无针给药装置和药筒组件供应链中断，可能导致自主给药生物製药价格上涨。此外，由于互惠关税以及不断升级的贸易摩擦和限制，全球经济和贸易将受到更广泛的负面影响。

糖尿病、心血管疾病和癌症等慢性疾病的增加，对穿戴式註射器市场的成长贡献巨大。例如，根据英国糖尿病协会（一家支持糖尿病患者的英国慈善机构）2023年4月的报告，英国约有430万人被诊断为糖尿病。其中，约90%患有第2型糖尿病，约8%患有第1型糖尿病，其余2%患有其他类型的糖尿病。慢性疾病患者的增加，推动了对治疗解决方案的需求，从而推动了穿戴式註射器市场的扩张。

预计未来几年，老龄人口的成长将成为穿戴式註射器市场扩张的驱动力。这类人群通常由65岁及以上的老年人组成，可穿戴注射器为他们提供了一种便捷的自我用药方式，减少了频繁就医的需求，同时提高了患者独立性和对治疗计划的依从性。例如，世界卫生组织（WHO）于2022年10月报告称，到2030年，全球整体六分之一的人口将达到60岁或以上，并预测2050年老年人口将达到21亿人。因此，老龄人口的成长是穿戴式註射器市场扩张的主要驱动力。

穿戴式註射器製造市场中的许多公司正专注于开发先进产品，例如体内注射器 (OBI)，以提高患者的便利性、改善对处方治疗的依从性并满足日益增长的自我管理生技药品的需求。体内注射器 (OBI) 是一种可穿戴的药物输送装置，旨在在特定时间内内皮下给药，为需要大容量或定期注射的患者提供便利。例如，2024 年 2 月，美国化疗Corherus Biosciences 推出了使用 LTS Sorel 穿戴式平台的先进药物输送装置 UDENYCA。该装置用于给药聚Pegfilgrastim- cbqv，这是Pegfilgrastim的生物仿製药，用于降低化疗后第二天发生发热性中性粒细胞减少症的风险，发热性中性粒细胞减少症是一种因感染疾病嗜中性白血球低下症。 OBI 确保准确的剂量和家庭管理的便利性，无需额外就诊。

为了增加市场收益，穿戴式註射器市场的主要企业越来越注重推出创新的药物输送设备，例如 enFuse 注射器。 enFuse 注射器设计用于自我给药大量药物，为患者提供舒适和便利。例如，2023 年 9 月，美国医疗科技公司 Enable Injections, Inc. 获得了美国食品药物管理局(FDA) 的 enFuse 注射器核准。这款穿戴式註射器用于皮下注射 EMPAVELI，这是 Apellis Pharmaceuticals Inc. 在美国销售的一种用于阵发性夜间血尿症(PNH) 成人的药物。 enFuse 注射器是一种小型穿戴式设备，可最大限度地减少对患者日常生活的干扰并简化自我给药过程。它允许免提给药，剂量最多为 25 毫升，适合在家中或临床环境中使用。 FDA核准enFuse注射器为患者提供了更方便的给药方式。

2023年6月，德国製药公司LTS LOHMANN Therapie-Systeme AG以未揭露的金额收购了Eitan Medical旗下的可穿戴注射器Sorrel业务。此次收购预计将拓宽LTS LOHMANN Therapie-Systeme AG的药物传输平台，并增强其在大分子和生技药品领域的产品组合。 Eitan Medical Ltd.是一家以色列医疗设备製造商，以开发创新药物输送解决方案（包括穿戴式註射器）而闻名。

穿戴式註射器市场的主要企业包括安进公司 (Amgen Inc.)、碧迪公司 (Becton Dickinson and Company, BD)、Enable Injections LLC、Insulet Corporation、Ypsomed Holding AG、美敦力 MiniMed 公司、Tandem Diabetes Care 公司、Valeritas 公司、West Pharmaceutical 公司、S医生PLC、United Therapeutics 公司、Buhler Motor GmbH、Debiotech SA、Cellnovo Group、EoFlow Co. Ltd.、CeQur SA、Haselmeier AG、强生公司、kaleo 公司、迈兰公司、Nemera Development SA、F. Hoffmann-La Roche Ltd. 和 Zosano Pharma 公司。

2024年，穿戴式註射器市场最大的地区是北美。西欧是穿戴式註射器市场的第二大分析地区。穿戴式註射器市场报告涵盖的地区包括亚太地区、西欧、东欧、北美、南美、中东和非洲。

穿戴式註射器市场报告涵盖的国家包括澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国、美国、义大利、西班牙和加拿大

穿戴式註射器市场涵盖体内和体外注射器等设备的销售。此市场的价值为出厂价，即产品製造商或生产商向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向最终客户销售的产品价值。该市场中的产品价值还包括产品製造商提供的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球穿戴式註射器：PESTEL分析（政治、社会、科技、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球穿戴式註射器市场：成长率分析
  • 全球穿戴式註射器市场表现：规模与成长，2019-2024
  • 全球穿戴式註射器市场预测：规模与成长，2024-2029 年，2034 年
  • 全球穿戴式註射器：总目标市场（TAM）

第六章 市场细分

  • 全球穿戴式註射器市场：按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 体内註射器
  • 离体注射器
  • 全球穿戴式註射器市场：按最终用户、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 诊所
  • 居家照护环境
  • 全球穿戴式註射器市场：按应用、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 免疫肿瘤学
  • 糖尿病
  • 心血管疾病
  • 其他用途
  • 全球穿戴式註射器市场：体内注射器细分（按类型）、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 基于补丁的注射器
  • 黏合剂注射器
  • 针头注射器
  • 无针注射器
  • 全球穿戴式註射器市场：离体注射器细分（按类型）、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 带式註射器
  • 手持式註射器
  • 夹式註射器

第七章 区域和国家分析

  • 全球穿戴式註射器市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球穿戴式註射器市场：依国家、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 穿戴式註射器市场：竞争格局
  • 穿戴式註射器市场：公司简介
    • Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Becton Dickinson and Company（BD）Overview, Products and Services, Strategy and Financial Analysis
    • Enable Injections LLC Overview, Products and Services, Strategy and Financial Analysis
    • Insulet Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Ypsomed Holding AG Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Medtronic MiniMed Inc.
  • Tandem Diabetes Care Inc.
  • Valeritas Inc.
  • West Pharmaceutical Services Inc.
  • Sensile Medical AG
  • Gerresheimer AG
  • Dexcom Inc.
  • Consort Medical plc
  • United Therapeutics Corporation
  • Buhler Motor GmbH
  • Debiotech SA
  • Cellnovo Group
  • EoFlow Co. Ltd.
  • CeQur SA
  • Haselmeier AG

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年穿戴式註射器市场：提供新机会的国家
  • 2029年穿戴式註射器市场：细分市场带来新机会
  • 2029年穿戴式註射器市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r32863u

Wearable injectors are specialized drug delivery devices that affix to the patient's body during the subcutaneous administration of drugs over a predetermined duration.

These wearable injectors come in two primary types are on-body injectors and off-body injectors. On-body injectors are drug delivery devices attached directly to the patient's skin, typically on the abdomen or the back of the patient's arm. They find applications in various medical fields, including immuno-oncology, diabetes, cardiovascular diseases, among others, and are employed across a range of healthcare settings, including hospitals, clinics, and home care.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The wearable injectors market research report is one of a series of new reports from The Business Research Company that provides wearable injectors market statistics, including wearable injectors industry global market size, regional shares, competitors with a wearable injectors market share, detailed wearable injectors market segments, market trends and opportunities, and any further data you may need to thrive in the wearable injectors industry. This wearable injectors market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The wearable injectors market size has grown rapidly in recent years. It will grow from $8.84 billion in 2024 to $9.84 billion in 2025 at a compound annual growth rate (CAGR) of 11.3%. The growth in the historic period can be attributed to chronic disease management, patient convenience, technological advancements, aging population.

The wearable injectors market size is expected to see rapid growth in the next few years. It will grow to $17.2 billion in 2029 at a compound annual growth rate (CAGR) of 15.0%. The growth in the forecast period can be attributed to personalized medicine, remote patient monitoring, drug development, chronic disease management. Major trends in the forecast period include biologics and large molecules, dual-chamber wearables, connected and smart devices, patch pump technology.

The forecast of 15.0% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for needle-free delivery mechanisms and drug cartridge assemblies, sourced from key regions such as India and Mexico, could lead to higher prices for self-administered biologic therapies.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rise in the prevalence of chronic conditions such as diabetes, cardiovascular diseases, and cancers has significantly contributed to the growth of the wearable injectors market. For example, in April 2023, a report from the British Diabetic Association, a UK-based charity supporting individuals with diabetes, highlighted that approximately 4.3 million people in the UK are diagnosed with diabetes. Of these, around 90% have type 2 diabetes, about 8% are diagnosed with type 1 diabetes, and the remaining 2% have other forms of diabetes. The increasing number of patients with diabetes and other chronic conditions has led to a greater demand for treatment solutions, driving the expansion of the wearable injectors market.

The increasing elderly population is expected to be a driving force behind the growth of the wearable injectors market in the future. This demographic consists of older adults, typically aged 65 and above, and wearable injectors offer them a convenient way to self-administer medications, fostering independence and adherence to treatment regimens while reducing the necessity for frequent hospital visits. For example, in October 2022, the World Health Organization reported that globally, one in six individuals would be 60 years old or older by 2030, and it is projected that there will be 2.1 billion elderly individuals by 2050. Hence, the growing geriatric population is a key driver of the wearable injectors market's expansion.

Many companies in the wearable injectors manufacturing market are focusing on developing advanced products such as on-body injectors (OBI) to enhance patient convenience, improve adherence to prescribed treatments, and meet the rising demand for self-administration of biologics. An On-Body Injector (OBI) is a wearable drug delivery device designed to administer medications subcutaneously over a specific period, providing convenience for patients who require large-volume or timed-dose injections. For example, in February 2024, Coherus BioSciences Inc., a US-based biotechnology company, launched UDENYCA, an advanced drug delivery device using the LTS Sorrel wearable platform. This device is designed to administer pegfilgrastim-cbqv, a biosimilar of pegfilgrastim, used the day after chemotherapy to reduce the risk of febrile neutropenia, a condition marked by fever and low white blood cell count due to infections. The OBI ensures precise dosing and convenience by enabling at-home administration, removing the need for additional clinic visits.

Major players in the wearable injectors market are increasingly focusing on introducing innovative medication delivery devices like the enFuse injector to enhance their revenue in the market. The enFuse injector is designed for the self-administration of high-volume drugs, offering patients comfort and convenience. For instance, in September 2023, Enable Injections, Inc., a US-based medical technology company, obtained approval from the US Food and Drug Administration (FDA) for the enFuse injector. This wearable injector is intended for the subcutaneous delivery of EMPAVELI, a medication used by adults with paroxysmal nocturnal hemoglobinuria (PNH) and marketed in the United States by Apellis Pharmaceuticals Inc. The enFuse injector is a compact, wearable device that simplifies the self-administration process with minimal disruption to patients' daily routines. It enables hands-free delivery of up to 25 mL, making it suitable for use at home or in clinical settings. The FDA approval of the enFuse injector provides patients with a more convenient way to administer their medication.

In June 2023, LTS LOHMANN Therapie-Systeme AG, a pharmaceutical company based in Germany, purchased the Sorrel wearable injection device business from Eitan Medical for an undisclosed sum. This acquisition is anticipated to broaden LTS LOHMANN Therapie-Systeme AG's range of drug delivery platforms and enhance its offerings in the areas of large molecules and biologics. Eitan Medical Ltd. is an Israeli medical device company known for its development of innovative drug delivery solutions, including wearable injectors.

Major companies operating in the wearable injectors market include Amgen Inc., Becton Dickinson and Company (BD), Enable Injections LLC, Insulet Corporation, Ypsomed Holding AG, Medtronic MiniMed Inc., Tandem Diabetes Care Inc., Valeritas Inc., West Pharmaceutical Services Inc., Sensile Medical AG, Gerresheimer AG, Dexcom Inc., Consort Medical PLC, United Therapeutics Corporation, Buhler Motor GmbH, Debiotech SA, Cellnovo Group, EoFlow Co. Ltd., CeQur SA, Haselmeier AG, Johnson & Johnson, kaleo Inc., Mylan N.V., Nemera Development S.A., F. Hoffmann-La Roche Ltd., Zosano Pharma Corporation

North America was the largest region in the wearable injectors market in 2024. Western Europe was the second-largest region in the wearable injectors market analysis. The regions covered in the wearable injectors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the wearable injectors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada

The wearable injectors market consists of sales of instruments such as on-body injectors and off-body injectors. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Wearable Injectors Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on wearable injectors market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for wearable injectors ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The wearable injectors market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: On-Body Injectors; Off-Body Injectors
  • 2) By End-User: Hospitals; Clinics; Homecare setting
  • 3) By Application: Immuno-Oncology; Diabetes; Cardiovascular Diseases; Other Applications
  • Subsegments:
  • 1) By On-Body Injectors: Patch-Based Injectors; Adhesive-Based Injectors; Needle-Based Injectors; Needle-Free Injectors
  • 2) By Off-Body Injectors: Belt-Based Injectors; Handheld Injectors; Clip-Based Injectors
  • Companies Mentioned: Amgen Inc.; Becton Dickinson and Company (BD); Enable Injections LLC; Insulet Corporation; Ypsomed Holding AG; Medtronic MiniMed Inc.; Tandem Diabetes Care Inc.; Valeritas Inc.; West Pharmaceutical Services Inc.; Sensile Medical AG; Gerresheimer AG; Dexcom Inc.; Consort Medical plc; United Therapeutics Corporation; Buhler Motor GmbH; Debiotech SA; Cellnovo Group; EoFlow Co. Ltd.; CeQur SA; Haselmeier AG; Johnson & Johnson; kaleo Inc.; Mylan N.V.; Nemera Development S.A.; F. Hoffmann-La Roche Ltd; Zosano Pharma Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Wearable Injectors Market Characteristics

3. Wearable Injectors Market Trends And Strategies

4. Wearable Injectors Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Wearable Injectors Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Wearable Injectors PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Wearable Injectors Market Growth Rate Analysis
  • 5.4. Global Wearable Injectors Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Wearable Injectors Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Wearable Injectors Total Addressable Market (TAM)

6. Wearable Injectors Market Segmentation

  • 6.1. Global Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • On-Body Injectors
  • Off-Body Injectors
  • 6.2. Global Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinics
  • Homecare setting
  • 6.3. Global Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Immuno-Oncology
  • Diabetes
  • Cardiovascular Diseases
  • Other Applications
  • 6.4. Global Wearable Injectors Market, Sub-Segmentation Of On-Body Injectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Patch-Based Injectors
  • Adhesive-Based Injectors
  • Needle-Based Injectors
  • Needle-Free Injectors
  • 6.5. Global Wearable Injectors Market, Sub-Segmentation Of Off-Body Injectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Belt-Based Injectors
  • Handheld Injectors
  • Clip-Based Injectors

7. Wearable Injectors Market Regional And Country Analysis

  • 7.1. Global Wearable Injectors Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Wearable Injectors Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Wearable Injectors Market

  • 8.1. Asia-Pacific Wearable Injectors Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Wearable Injectors Market

  • 9.1. China Wearable Injectors Market Overview
  • 9.2. China Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Wearable Injectors Market

  • 10.1. India Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Wearable Injectors Market

  • 11.1. Japan Wearable Injectors Market Overview
  • 11.2. Japan Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Wearable Injectors Market

  • 12.1. Australia Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Wearable Injectors Market

  • 13.1. Indonesia Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Wearable Injectors Market

  • 14.1. South Korea Wearable Injectors Market Overview
  • 14.2. South Korea Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Wearable Injectors Market

  • 15.1. Western Europe Wearable Injectors Market Overview
  • 15.2. Western Europe Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Wearable Injectors Market

  • 16.1. UK Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Wearable Injectors Market

  • 17.1. Germany Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Wearable Injectors Market

  • 18.1. France Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Wearable Injectors Market

  • 19.1. Italy Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Wearable Injectors Market

  • 20.1. Spain Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Wearable Injectors Market

  • 21.1. Eastern Europe Wearable Injectors Market Overview
  • 21.2. Eastern Europe Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Wearable Injectors Market

  • 22.1. Russia Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Wearable Injectors Market

  • 23.1. North America Wearable Injectors Market Overview
  • 23.2. North America Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Wearable Injectors Market

  • 24.1. USA Wearable Injectors Market Overview
  • 24.2. USA Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Wearable Injectors Market

  • 25.1. Canada Wearable Injectors Market Overview
  • 25.2. Canada Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Wearable Injectors Market

  • 26.1. South America Wearable Injectors Market Overview
  • 26.2. South America Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Wearable Injectors Market

  • 27.1. Brazil Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Wearable Injectors Market

  • 28.1. Middle East Wearable Injectors Market Overview
  • 28.2. Middle East Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Wearable Injectors Market

  • 29.1. Africa Wearable Injectors Market Overview
  • 29.2. Africa Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Wearable Injectors Market Competitive Landscape And Company Profiles

  • 30.1. Wearable Injectors Market Competitive Landscape
  • 30.2. Wearable Injectors Market Company Profiles
    • 30.2.1. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Becton Dickinson and Company (BD) Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Enable Injections LLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Insulet Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Ypsomed Holding AG Overview, Products and Services, Strategy and Financial Analysis

31. Wearable Injectors Market Other Major And Innovative Companies

  • 31.1. Medtronic MiniMed Inc.
  • 31.2. Tandem Diabetes Care Inc.
  • 31.3. Valeritas Inc.
  • 31.4. West Pharmaceutical Services Inc.
  • 31.5. Sensile Medical AG
  • 31.6. Gerresheimer AG
  • 31.7. Dexcom Inc.
  • 31.8. Consort Medical plc
  • 31.9. United Therapeutics Corporation
  • 31.10. Buhler Motor GmbH
  • 31.11. Debiotech SA
  • 31.12. Cellnovo Group
  • 31.13. EoFlow Co. Ltd.
  • 31.14. CeQur SA
  • 31.15. Haselmeier AG

32. Global Wearable Injectors Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Wearable Injectors Market

34. Recent Developments In The Wearable Injectors Market

35. Wearable Injectors Market High Potential Countries, Segments and Strategies

  • 35.1 Wearable Injectors Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Wearable Injectors Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Wearable Injectors Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer